187 related articles for article (PubMed ID: 10204147)
1. [Application of BMD models in quantitative evaluation of carcinogenic risk].
Szymczak W
Med Pr; 1998; 49(6):579-87. PubMed ID: 10204147
[TBL] [Abstract][Full Text] [Related]
2. A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25.
Sanner T; Dybing E; Willems MI; Kroese ED
Pharmacol Toxicol; 2001 Jun; 88(6):331-41. PubMed ID: 11453374
[TBL] [Abstract][Full Text] [Related]
3. [Quantitative evaluation for risk assessment of neoplasms caused by exposure to chemical substances].
Szymczak W
Med Pr; 2000; 51(6):625-36. PubMed ID: 11288691
[TBL] [Abstract][Full Text] [Related]
4. Regulatory cancer risk assessment based on a quick estimate of a benchmark dose derived from the maximum tolerated dose.
Gaylor DW; Swirsky Gold L
Regul Toxicol Pharmacol; 1998 Dec; 28(3):222-5. PubMed ID: 10049793
[TBL] [Abstract][Full Text] [Related]
5. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
Filipsson AF; Sand S; Nilsson J; Victorin K
Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
[TBL] [Abstract][Full Text] [Related]
6. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
[TBL] [Abstract][Full Text] [Related]
7. Quantitative approaches to human risk assessment for noncancer health effects.
Kimmel CA
Neurotoxicology; 1990; 11(2):189-98. PubMed ID: 2234540
[TBL] [Abstract][Full Text] [Related]
8. [Evolution of industrial toxicology toward vanishing doses and the human genome].
Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
[TBL] [Abstract][Full Text] [Related]
9. Precision of benchmark dose estimates for continuous (nonquantal) measurements of toxic effects.
Gaylor DW; Chen JJ
Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 1):19-23. PubMed ID: 8921542
[TBL] [Abstract][Full Text] [Related]
10. [The evaluation of occupational exposure to carcinogenic substances: limit values and risk assessments].
Apostoli P; Porru S; Alessio L
G Ital Med Lav; 1990; 12(5-6):201-7. PubMed ID: 2152617
[TBL] [Abstract][Full Text] [Related]
11. [Methods of extrapolating risk from from high to low doses and their effect on determining MAC values].
Szymczak W
Med Pr; 1996; 47(5):501-9. PubMed ID: 9026630
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
Preston RJ
Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
[TBL] [Abstract][Full Text] [Related]
13. [Quantitative methods of cancer risk assessment in exposure to chemicals].
Szymczak W
Med Pr; 2009; 60(3):215-21. PubMed ID: 19746890
[TBL] [Abstract][Full Text] [Related]
14. Statistics for risk assessment of chemical carcinogens.
Chen JJ; Chen YJ; Cheng KF
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(4):281-312. PubMed ID: 18000784
[TBL] [Abstract][Full Text] [Related]
15. Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.
Zhu Y; Wang T; Jelsovsky JZ
Risk Anal; 2007 Apr; 27(2):447-65. PubMed ID: 17511711
[TBL] [Abstract][Full Text] [Related]
16. [Methods of risk assessment from data of experimental carcinogenesis studies].
Roller M; Csicsaky M; Pott F
Zentralbl Hyg Umweltmed; 1992 Mar; 192(6):479-93. PubMed ID: 1315551
[TBL] [Abstract][Full Text] [Related]
17. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
18. Update of potency factors for asbestos-related lung cancer and mesothelioma.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
[TBL] [Abstract][Full Text] [Related]
19. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.
Shipp A; Lawrence G; Gentry R; McDonald T; Bartow H; Bounds J; Macdonald N; Clewell H; Allen B; Van Landingham C
Crit Rev Toxicol; 2006; 36(6-7):481-608. PubMed ID: 16973444
[TBL] [Abstract][Full Text] [Related]
20. Health assessment of phosgene: approaches for derivation of reference concentration.
Gift JS; McGaughy R; Singh DV; Sonawane B
Regul Toxicol Pharmacol; 2008 Jun; 51(1):98-107. PubMed ID: 18440110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
